Journal of Commercial Biotechnology

I’ve recently joined the Journal of Commercial Biotechnology as managing editor. Drop me a line if you would like to make a submission.

The most recent issue, edited by Neil Henderson, has just been published:

Volume 13, Issue 3

• When should you fire the founder?

William Bains

• Constructing a processual model of communication in new product development from a multiple case study of biotechnology SMEs

Jennifer Frahm, David C Ireland and Damian Hine

• A maturing industry: Strategic patenting trends, US and academic dominance, and the global biotechnology landscape

Gareth Williams

• Measuring performance of field-medical programmes: Medical science liaison metrics consensus

Jane Chin

• The commercialisation of bioinformatics and the threat of open-source software

Joseph F Greco

• Intellectual property issues in nanotechnology

Lars Genieser and Michael Gollin

• Fostering the process of adoption of personalised medicine: A matter of communication or a matter of cost?

Pedro Reinares Lara and Emma Gutierrez de Mesa

• Changing hopes and concerns about gene therapy in Japan

Darryl Macer, Yoshihiro Okada, Makoto Nakagawa, MaryAnn Chen Ng and Masakazu Inaba

• Legal and Regulatory Update

ReedSmith

The Journal of Commercial Biotechnology is online at http://www.palgrave-journals.com/jcb. If purchasing a subscription, please use subscriber code NH0707G01.